Opdivo has been listed in the United States for the treatment of lung cancer. Many cancer patients cannot go abroad for treatment for various reasons. Consult Opdivo on how to use it and hope to be ab...
On January 13, 2015, Huanyu Dakang Medical News pharmaceutical giant Squibb Company ushered in a good start in 2015. The anti-cancer immunotherapy drug nivolumab developed by the company was approved...
1. Diagnosis and first treatment of lung cancerPatient Lu was diagnosed with lung adenocarcinoma and lymph node metastasis on August 26, 2005. A left lower lobectomy was performed on September 22, 20...
1. Individualized scope of lung parenchymal resection Since the 1960s, regardless of tumor size, anatomical lobectomy has become the standard for surgical treatment of non-small cell lung cancer . ...
Burden of liver cancer Liver cancer is a common malignant tumor accounting for more than half of the global liver cancer. The onset of hepatocellular carcinoma (HCC) is hidden, and early symptoms...
Liver cancer Liver cancer is currently the fifth most common cause of cancer-related death in the world. The current first-line systemic treatment drug is mainly sorafenib, but usually only prolongs ...
Cases of NK cell immunotherapy for advanced liver cancer 92-year-old advanced cancer patient has complete remission Seven years ago, Ms. M, who was in her 80s, was diagnosed with hepatocellular carcin...
Proton therapy for liver cancer, prolonged overall survival of patients with hepatocellular carcinoma proton therapyHepatocellular carcinoma is the most common type of liver cancer, with more than 700...
Speaking of tumors is always daunting, but in fact, as long as it stays in place, it is not so terrible, we can just uproot it. The malignant tumor is terrible because it is extremely invasive and me...
The incidence of liver cancer in China is very high, because liver cancer is difficult to find in the early stage of the disease. Once the diagnosis is often in the middle and late stages, the optimal...